Instruments have to undergo evaluation at three levels. Firstly, the manufacturer has to evaluate in order to produce data on which to base performance claims-for example, for inclusion in sales literature or for submission to a regulatory authority, such as the Food and Drug Administration in the USA. Secondly, evaluation is done on behalf of would-be users by laboratories acting for government departments and organisations such as the British Committee for Standardisation in Haematology and the College of American Pathologists. At this level, among other things, the evaluator seeks to validate the manufacturer's performance claims and look for inherent hazards in use. Thirdly, the would-be user evaluates whether a particular instrument-rather than the one tested elsewhere-is reliable and whether the special requirements of his own laboratory are met. In doing this he takes account of sample volume, workload and range of pathological states usually encountered.
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The International Committee for Standardisation in Haematology (ICSH): "Protocol for type testing equipment and apparatus for haematological analysis"' provides general guidance for manufacturers. Shinton et a12 have described a protocol for evaluation of coagulometers. Broughton et al3 have recommended a scheme for the evaluation of instruments for use in clinical chemistry laboratories and Percy-Robb et a!4 have recommended a scheme for the evaluation of kits in the clinical chemistry laboratory.
The object of this paper is to provide general guidance and a systematic approach, to meet haematological requirements, for evaluation at the second and third levels. The principles outlined are common to the evaluation of a wide range of instruments and should be generally applicable to reagents and kits as well. The principles should enable the evaluator to adapt a protocol specifically for his own requirements. Appendix 2 is a protocol *Prepared with the co-operation of the General Haematology Panel of the British Committee for Standardisation in Haematology.
Accepted for publication 8 March 1982 for evaluation of automated blood cell counters which illustrates the proposed approach. It is hoped that adoption of this format, which follows generally that of ICSH' with some additions, will allow comparison of evaluation reports and exchange of information.
Evaluation at the second and third levels may be divided into a preliminary planning stage, followed by a technical stage which involves all the work necessary to assess the performance of the item under evaluation and to determine its practical use.
Preliminary stage 1(a) General information
Where relevant, the following should be checked before delivery: descriptive name of instrument, manufacturer and marketing company, list price including that for optional attachments, rental or leasing arrangements, terms of guarantee, cost of maintenance contract, charges for visits, cost and availability of spare parts and consumables. It is helpful to know the length of time in use in the country of origin and approximate number and distribution, earlier models and/or antecedent apparatus. (b) Space and service requirements The following should be noted-floor area (if freestanding) or bench top space required, together with weight; details of the required electrical supply and other necessary services-for example, water (pressure and quality), compressed air, vacuum, drainage; need to provide a controlled environment-for example, for computerised equipment; any effect on the environment-for example, noise, vibration, heat production and any modification to the laboratory.
(c) Instruction book This should be assessed in terms of clarity, lack of ambiguity and ease of reference. Particular attention should be made to that part which refers to maintenance carried out by the operator and "in-use" fault finding. (ii) Variables whose magnitude should be unaffected by dilution Certain haematological variables-for example, the red cell indices. should not be affected by dilution of the sample. Such data can be plotted out as the result against the concentration when a horizontal line with zero slope should be obtained. The method of statistical analysis is given in Appendix 1.
(b) Precision Precision is established by testing the sample on two or more occasions. It is usual to consider precision when the sample is assayed repeatedly within one batch of samples (within batch or replicate precision) as well as when the sample is assayed in two or more batches (between batch of duplicate precision). Precision may be quantified using the coefficient of variation (CV) as detailed in Appendix 1.
The organisation of the precision study will depend on the availability of samples. Where a sample is divided into aliquots each specimen container should be given a number and the order of sampling be regulated by use of a Table of random numbers. This procedure should minimise sampling errors. Ideally, precision studies should be made over the whole pathological range. Samples should certainly be examined in the high, low and intermediate ranges. When samples in any specified range are studied it is better to assay more samples fewer times than to assay a few samples more times but the final decision may have to be a compromise determined by availability of material. Sample storage and stability characteristics will determine whether it is possible to assay the sample in only two batches or whether they can be incorporated into several, so giving a better estimate of between batch variability. Blood counts on an automated system can only be done in relatively few batches-for example, two batches on the same day, the counter being switched off and recalibrated in between. Serum or plasma samples could be divided into aliquots, deep frozen and then assayed in many batches over a long period. The results should be analysed separately for each part of the pathological range using an analysis of variance, detailed of which are given in Appendix As many unselected samples should be studied as possible, the results analysed using the statistical procedure described in Appendix 1. If the Shinton, England, Kennedy unselected series does not give sufficient information about samples at the extremes of the pathological range, such samples should be selected and studied in detail separately. The full range of concentrations expected in clinical practice must be studied. The results obtained with the selected samples should not be merged with those in the unselected series since this would negate the statistical analysis.
(e) Analysis of data General guidelines for the statistical analysis of results are given in Appendix 1. All the methods suggested are based upon the assumption that the observations are normally distributed and serious violations of this assumption may invalidate the statistical analysis. Measurements will not be normal if the frequency distribution curve is skewed or if the scatter of the results increase with magnitude-for example, when results by method A is plotted against those obtained by method B.
It may be that the distributions are normal when their logarithm is taken-for example, white cell and platelet counts and serum vitamin B12; if so, the logarithms of the results should be analysed rather than the results themselves. In such complex situations further statistical advice may be necessay.
EFFICIENCY ASSESSMENT
An overall assessment should be made on the basis of the data available. Note should be made of any investigations that are outside the claims made for the instrument by the manufacturer.
(a) Throughput This should be determined with reference to number of samples processed per batch with the inclusion of standards and drift control materials. The optimum number of samples that can be handled in a normal working day should be determined. Variables whose magnitude should be unaffected by dilution-for example, MCV The data should be analysed as above to see whether a parabolic relation is better than a linear one. If the data appears to be linear the slope of the line should be tested to see if it is zero-that is, does b= 0 ? (See section D for calculation). The variable can be assumed to be unaffected by dilution if the parabolic relation is no better than the linear one and "b" is not significantly different from zero. Test a high sample consecutively thrice (il, i2, i3) followed immediately by testing a low sample consecutively thrice (j,, j2, j3) . Carry-over % is then:
Example Results obtained for red cell counts were 6-28, 6-27, 6-30, Regression analysis may be used to study the effect of dilution by plotting result (y) against concentration (x) and fitting a line y = a + bx as described in section A. In this case concentration (x) is assumed to be error free and only one a and b coefficient can be calculated, those for the regression line of y and x-that is, the line to be used if, given x, one wishes to calculate y. It is, therefore, quite appropriate to test whether a or b = 0. However, regression analysis can also be used to assess accuracy or comparability by plotting the result (y) by the new method against (x) the one by the reference or best available method. In this case there are two regression lines, for y on x and for x on y, depending on whether y is to be predicted from x or vice versa.
Because there are two regression lines there are two possible values for a and two for b. If the two values for b are multiplied together and the square root taken the correlation coefficient, r, is obtained (note that r should not be calculated for the effect of dilution since there is only one regression line). The correlation coefficient is usually very close to 1-0 when methods are compared and is therefore of very little use for assessing how well methods agree. Instead the SD of the points about the regression line (of y on x) should be determined.
Example Packed cell volumes (PCV) on 18 samples were determined on the automated counter being tested (y values) and the best available automated counter (x values). The data have been multiplied by 1000 for convenience and are presented below. In practice considerably more than 18 samples would be studied. 281  249  422  361  489  383  291  235  453  393  510  433  338  287  463  394  523  453  365  284  464  386  531  452  385  321  464  387  618  507  417  345  472  393  681 Samples Fresh blood samples, collected through a needle of bore 19G, obtained from volunteer donors and patients who have given consent following explanation of the purpose to which the blood will be used. These will be required from subjects wiith the following states: The volume of blood to be collected will depend upon the requirements of the instrument under test. A calculation for each part of the assessment must be made. In view of the total volume of blood required, it will probably be necessary to carry out each part of assessment on samples from different subjects. For the same reason, precision of haemoglobin and red cell counting at the lower end of the range must be based on at least 10 paired samples.
Reference material ICSH-related hemiglobincyanide (HiCN) reference preparation" 10 ml 
